News

In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.



SGLT2 inhibitors may lower the risk of major cardiovascular events

By Linda Carroll (Reuters Health) - Sodium glucose transporter 2 (SGLT2) inhibitors may lower the risk of major cardiovascular events in people with type 2 diabetes more effectively than dipeptidyl

Global COVID-19 death toll could hit 2 million before vaccine in wide use -WHO

By Reuters Staff GENEVA/ZURICH (Reuters) - The global death toll from COVID-19 could double to 2 million before a successful vaccine is widely used and could be even higher without concerted action to

Transcranial low-level light therapy safe for moderate TBI

By Lisa Rapaport (Reuters Health) - Transcranial low-level light therapy is safe for patients with moderate traumatic brain injury (TBI) and appears to impact the brain in measurable ways that might

Two charged in deadly COVID-19 outbreak at Massachusetts veterans' home

By Nate Raymond and Maria Caspani BOSTON (Reuters) - Two former heads of a Massachusetts veterans home have been indicted on criminal neglect charges for their roles in handling a COVID-19 outbreak

Johnson & Johnson COVID-19 vaccine produces strong immune response in early trial

By Vishwadha Chander (Reuters) - A single dose of Johnson & Johnson's experimental COVID-19 vaccine produced a strong immune response against the novel coronavirus in an early-to-mid stage clinical

'It worked': In New York City, pandemic-inspired outdoor dining to become permanent

By Barbara Goldberg NEW YORK (Reuters) - New York is committed to making outdoor dining a permanent option for the thousands of restaurants that have embraced the concept since the coronavirus

Florida governor removes COVID-19 restrictions on restaurants, bars

By Reuters Staff (Reuters) - Florida Governor Ron DeSantis on Friday lifted all COVID-19 restrictions on businesses, including restaurants and bars, saying the threat of the coronavirus pandemic had

Space bubbles ease New York restaurant troubles

By Aleksandra Michalska NEW YORK (Reuters) - Space bubbles are frothing up business at a New York bistro, offering fresh air in safe capsules on sidewalks for customers on guard against the

Opportunistic screening doesn't find more AF cases

By Reuters Staff NEW YORK (Reuters Health) - Opportunistic screening of primary-care patients 65 and older for atrial fibrillation (AF) does not increase detection, according to new findings. "Future

Telemedicine promising for blood pressure management, but many challenges remain

By Marilynn Larkin NEW YORK (Reuters Health) - A new position paper shows that telemedicine is useful for optimizing the management of hypertensive patients, particularly those who are difficult to

CORRECTED-COVID-19 croup may be more severe than typical croup

(Corrects para 11 of Sept. 24 story, to indicate that all croup patients are offered COVID-19 testing.) By Megan Brooks NEW YORK (Reuters Health) - Clinicians from Virginia report what they believe

Medical students can use tomatoes for skin-biopsy training

By Carolyn Crist NEW YORK (Reuters Health) - Tomatoes can be a great option to introduce medical students to hands-on shave biopsy training, according to a new report. Tomatoes are affordable, widely

Obesity rising among hospitalized Crohn's patients

By Reuters Staff NEW YORK (Reuters Health) - The percentage of hospitalized Crohn's disease (CD) patients with obesity rose sharply over the past two decades, while the proportion of malnourished

Community isolation facilities useful for managing COVID-19 pandemic

By Will Boggs MD NEW YORK (Reuters Health) - Rapidly deployable community isolation facilities have proven effective for managing the COVID-19 pandemic in Singapore, according to a new report. "

New drug shows promise in metastatic prostate cancer

By Megan Brooks NEW YORK (Reuters Health) - The experimental oral tubulin inhibitor VERU-111 has shown antitumor activity in men with metastatic castration-resistant prostate cancer (mCRPC) and has a

Commercial antibody tests perform well in patients recovered from COVID-19

By Will Boggs MD NEW YORK (Reuters Health) - Most commercial serological assays accurately detect anti-SARS-CoV-2 antibodies in patients who have recovered from COVID-19, according to a comparative

Preop tests that delay cataract surgery tied to falls in older people

By David Douglas NEW YORK (Reuters Health) - Postponing cataract surgery because of standard preoperative testing may increase the risk of falls in older people, according to a new study. "We've known

UK study shows rapid test has diagnostic sensitivity over 99%

By Reuters Staff LONDON (Reuters) - A new rapid test for COVID-19 has over 99% diagnostic sensitivity in early studies, scientists assessing the test at the University of Oxford said on Friday. Public

Some northern hemisphere countries struggling to source more flu vaccines -WHO

By Emma Farge and Stephanie Nebehay GENEVA (Reuters) - Some northern hemisphere countries are having trouble obtaining additional flu vaccines amid increased demand, but health workers and the elderly

New COVID-19 cases in England accelerating sharply: ONS survey

By Reuters Staff LONDON (Reuters) - The number of people in England with COVID-19 jumped by 73% in the latest week to Sept. 19, according to an official estimate that underscored the resurgence of the

Endo starts manufacturing Novavax's potential COVID-19 vaccine

By Reuters Staff (Reuters) - Generic drugmaker Endo said on Friday it was manufacturing Novavax Inc's experimental COVID-19 vaccine. The news comes a day after Novavax launched a late-stage trial of

J&J signs manufacturing deal with GRAM for potential COVID-19 vaccine

By Reuters Staff (Reuters) - Johnson & Johnson has signed a manufacturing deal for its coronavirus vaccine candidate with Grand River Aseptic Manufacturing Inc, the contract manufacturing organization

Olympics-Tokyo organisers outline steps for 'simplified' Games

By Kiyoshi Takenaka TOKYO (Reuters) - Organisers of the Tokyo Olympics on Friday proposed cutting back the number of staff at next year's Summer Games and shortening the opening period for training

Expert-center referral after pancreatectomy does not improve outcomes

By Will Boggs MD NEW YORK (Reuters Health) - Transfer of patients to expert centers after pancreatectomy does not appear to improve outcomes, according to a database study. Interhospital transfer (IHT

DCIS linked to higher breast cancer mortality, despite treatment

By Marilynn Larkin NEW YORK (Reuters Health) - The risk of dying from breast cancer is about three times higher in women with carcinoma in situ (DCIS) than in the general population, even after

Ban on cornea donation from gay and bisexual men outdated, wastes eyes

By Linda Carroll (Reuters Health) - The current U.S. ban on cornea donation from men who have had sex with men in the prior five years may result in as many as 3,000 potential corneas being wasted

Arthroscopic partial meniscectomy tied to radiographic knee osteoarthritis

By Lisa Rapaport (Reuters Health) - Patients with a degenerative meniscus tear who get arthroscopic partial meniscectomy have similar five-year outcomes and increased risk of radiographic knee

U.S. vaccine program chief backs stricter rules for emergency use of COVID-19 shot

By Julie Steenhuysen CHICAGO (Reuters) - The scientific head of the U.S. government program designed to speed development of COVID-19 vaccines said on Thursday he supports stricter rules to grant

Cuomo says New York to review any COVID-19 vaccine authorized by federal govt

By Maria Caspani (Reuters) - New York Governor Andrew Cuomo on Thursday said the state will carry out its own review of coronavirus vaccines authorized or approved by the federal government due to

Motivational interviewing can reduce adolescent alcohol use

By Lisa Rapaport (Reuters Health) - Motivational interviewing can help reduce the frequency of adolescent alcohol use and how often they experience problems related to substance use, a meta-analysis

Pfizer partner BioNTech sees no role for its vaccine in UK challenge trial

By Reuters Staff FRANKFURT (Reuters) - Pfizer's German development partner BioNTech on Thursday joined other leading COVID-19 vaccine developers in ruling out participation in British plans to test

Cases of nut anaphylaxis spike in children at Halloween and Easter

By Linda Carroll (Reuters Health) - The number of children showing up in emergency departments with anaphylaxis may spike during Halloween and Easter, a new study suggests. Canadian researchers found

UK's Integumen unveils prototype COVID-19 breath test

By Reuters Staff LONDON (Reuters) - Integumen, a British company that developed a system to detect the COVID-19 virus in waste water, said the same technology could be deployed in a personalised

Becton Dickinson reaches $60 million settlement over pelvic mesh devices

By Jonathan Stempel NEW YORK (Reuters) - Becton Dickinson and Co said on Thursday it has reached a $60 million settlement with the attorneys general of 48 U.S. states and Washington D.C., resolving

COVID-19 may damage monocytes in bone marrow

By Reuters Staff (Reuters) - Even the bone marrow may not be a safe harbor from the effects of SARS-CoV-2, according to a study that found previously unrecognized changes in the innate immune

Melanoma patients still at higher risk for new malignancy after successful systemic immunotherapy

By David Douglas NEW YORK (Reuters Health) - Patients successfully treated for metastatic melanoma with immune-checkpoint inhibitors remain at increased risk for developing new primary cutaneous

Peer-support programs can help parents of gender-diverse youth

By Carolyn Crist NEW YORK (Reuters Health) - Parents of transgender, gender-nonconforming or gender-diverse youth may seek support from other parents to gain a greater understanding of the resources

Rates of recurrent CHD events dropping in U.S.

By Anne Harding NEW YORK (Reuters Health) - Recurrent coronary heart disease (CHD) events declined for both men and women from 2008 to 2017, with a greater proportional decline for women, according to

Hispanic, Black, poor children more likely to test positive for SARS-CoV-2

By Will Boggs MD NEW YORK (Reuters Health) - Black and Hispanic children and those from lower socioeconomic groups are more likely than others to test positive for SARS-CoV-2, according to a new U.S.

Dapagliflozin again shows kidney, cardiovascular benefit beyond glucose control

By Reuters Staff (Reuters Health) - The diabetes drug dapagliflozin can prevent decline in kidney function among patients with chronic kidney disease, according to new results from the DAPA-CKD trial.

Glycans in SARS-CoV-2 spike protein play key role in binding to host cells

By Will Boggs MD NEW YORK (Reuters Health) - Glycans coating the spike protein of SARS-CoV-2 facilitate conformational changes needed to bind to ACE2 and infect host cells, researchers report. "Our

COVID-19 croup may be more severe than typical croup

By Megan Brooks NEW YORK (Reuters Health) - Clinicians from Virginia report what they believe are the first documented cases of croup as a manifestation of SARS-CoV-2 infection. The limited experience

High COVID-19 mortality seen in assisted-living facilities

By Reuters Staff (Reuters) - Data compiled from more than 4,600 assisted living facilities in seven U.S. states through the end of May showed a four-fold higher COVID-19 fatality rate than in the

CORRECTED-High-resolution CT no extra help in fracture risk screening in women

(Corrects first para of Sept. 15 story by adding missing text.) By Reuters Staff NEW YORK (Reuters Health) - High-resolution peripheral quantitative computed tomography (HR-pQCT) does not improve upon

AstraZeneca still waiting for FDA go-ahead to resume U.S. trial

By Ludwig Burger and Caroline Copley FRANKFURT (Reuters) - AstraZeneca is still waiting for the U.S. drug regulator to approve the restart of the clinical trial of its potential COVID-19 vaccine in

As COVID surges in Europe, officials warn of "twindemic" with flu

By Kate Kelland LONDON (Reuters) - A surge in COVID-19 cases in Europe risks becoming a deadly double epidemic of flu and coronavirus infections, EU health officials warned on Thursday as they urged

England Test and Trace reports tripling of COVID-19 cases since late August

By Reuters Staff LONDON (Reuters) - Three times as many people tested positive for COVID-19 in England in latest weekly figures compared to the end of August, NHS Test and Trace said on Thursday, with

COVID rising again in Sweden amid return to 'hugs and parties' -PM

By Reuters Staff STOCKHOLM (Reuters) - Some areas of Sweden are seeing a worrying resurgence of coronavirus infections because many people seem to have set aside months of caution in favour of full-on

Trump says may block stricter FDA guidelines for COVID-19 vaccine

By Jeff Mason WASHINGTON (Reuters) - U.S. President Donald Trump said on Wednesday he may or may not approve any new, more stringent FDA standards for an emergency authorization of a COVID-19 vaccine,

EXCLUSIVE-Top adviser steps aside from FDA COVID-19 vaccine reviews over potential conflict

By Dan Levine and Marisa Taylor (Reuters) - A physician who heads the influential U.S. Food and Drug Administration vaccine advisory committee recused herself from the panel's review of COVID-19

Parental touch soothes pain signals in babies' brains

By Kate Kelland LONDON (Reuters) - Newborn babies undergoing a painful heel prick blood test have a reduced response to the pain signals in their brains if they are held by a parent with skin-to-skin

Houston study: More contagious coronavirus strain now dominates

By Deena Beasley (Reuters) - The first study to analyze the structure of the novel coronavirus from two waves of infection in a major city found that a more contagious strain dominates recent samples,

REFILE-Medical treatment likely bests endovascular therapy for symptomatic intracranial artery stenosis

(Changes "ICAD" to "ICAS" in para 3 of Sept. 9 story.) By Marilynn Larkin NEW YORK (Reuters Health) - In patients with symptomatic intracranial atherosclerotic stenosis (ICAS), endovascular therapy (

REFILE-Life-prolonging cancer treatments should continue: ESMO

(Corrects spelling of Herceptin in para 3 of July 31 story.) By Reuters Staff (Reuters Health) - In most cases, cancer treatment that improves a patient's odds of survival should not be stopped or

OTC cognitive supplements may contain multiple unapproved drugs

By Lisa Rapaport (Reuters Health) - Over-the-counter supplements promoted as brain boosters may contain a variety of unapproved drugs in doses and combinations that could be harmful, a new study finds

Statins tied to lower risk of severe COVID-19, shorter recovery times

By Lisa Rapaport (Reuters Health) - Patients hospitalized with COVID-19 may have a lower risk of severe disease and faster recovery times if they were taking statins prior to admission, a new study

Low-dose zinc effective against acute childhood diarrhea

By Gene Emery (Reuters Health) - Doctors who use zinc to treat children for acute diarrhea can throttle back on the recommended dose and may, in the process, prevent the vomiting that can accompany

Ertugliflozin passes post-approval cardiovascular safety test

By Gene Emery (Reuters Health) - Oral ertugliflozin, approved in December 2017 as a therapy for type 2 diabetes, shows no signs of producing major cardiovascular problems and appears to reduce

Genetic testing may miss epivariants that contribute to disease

By Marilynn Larkin NEW YORK (Reuters Health) - Standard DNA-based genetic testing could miss epigenetic variants linked to disease, researchers say. "Often patients who appear to have a genetic

Supportive care suffices for most children with COVID-19, new guidance suggests

By Marilynn Larkin NEW YORK (Reuters Health) - Supportive care is sufficient to treat the majority of children with COVID-19, since most will be only mildly ill, an expert pediatric infectious

UPDATE 1-J&J kicks off study of single-shot COVID-19 vaccine in 60,000 volunteers

(Recasts first paragraph, adds details on second, two-dose study) By Julie Steenhuysen CHICAGO (Reuters) - Johnson & Johnson on Wednesday began a 60,000-person trial of an experimental single-shot

It may take several tries to find right COVID-19 vaccine, PAHO director says

By Julia Symmes Cobb BOGOTA (Reuters) - It may take several tries to find the right vaccine for COVID-19, the Pan American Health Organization's (PAHO) director Carissa Etienne said on Wednesday, as

FOCUS-Positive about flying? Airlines look to COVID tests that give results in minutes

By John Miller and Emilio Parodi ZURICH/MILAN (Reuters) - European airlines are pinning hopes on pre-flight COVID-19 tests that deliver results as fast as pregnancy tests to help restore passengers'

Most Americans to be vaccinated for COVID-19 by July, CDC chief expects

By Reuters Staff (Reuters) - A top U.S. health official told a U.S. Senate committee on Wednesday that he expects COVID-19 vaccinations to take place over many months and that most Americans could be

UPDATE 1-UK to host 'human challenge' trials for COVID-19 vaccines - FT

(Adds statements from Imperial College London and 1Day Sooner) By Reuters Staff (Reuters) - Britain will host clinical trials where volunteers are deliberately infected with the new coronavirus to

J&J kicks off final study of single-shot COVID-19 vaccine in 60,000 volunteers

By Julie Steenhuysen CHICAGO (Reuters) - Johnson & Johnson on Wednesday kicked off a final 60,000-person trial of a single-shot COVID-19 vaccine that potentially would simplify distribution of

Madrid pleads for more doctors, police as coronavirus cases surge

By Reuters Staff MADRID (Reuters) - Authorities in Spain's Madrid region on Wednesday requested urgent help to hire hundreds of foreign doctors and reinforce police, as they mulled widening a partial

Novartis faces delay after FDA asks for another Zolgensma study

By John Miller ZURICH (Reuters) - Novartis's bid to expand its $2.1 million-per-patient gene therapy Zolgensma to more spinal muscular atrophy patients faces a possible delay after U.S. regulators

German doctor held on suspicion of drugging, raping patients -media report

By Reuters Staff BIELEFELD, Germany (Reuters) - A hospital doctor in Germany has been arrested on suspicion of sedating women who had come to him for an MRT scan, and then filming himself raping them,

Roche Alzheimer's drug fails, joining long list of trial flops

By Reuters Staff ZURICH (Reuters) - An experimental Alzheimer's drug from Roche and AC Immune failed to slow cognitive and functional decline in a trial, the Swiss companies said on Wednesday, in a

Treatment times of acute STEMI have increased with COVID-19 pandemic

By Will Boggs MD NEW YORK (Reuters Health) - Times to treatment and mortality of acute ST-segment elevation myocardial infarction (STEMI) have increased since the onset of the COVID-19 pandemic,

Proton-pump inhibitors may reduce benefits of atezolizumab in urothelial carcinoma

By Will Boggs MD NEW YORK (Reuters Health) - The use of proton-pump inhibitors (PPIs) is associated with worse overall survival in patients with urothelial carcinoma treated with the immune-checkpoint

Bicuspid-aortic-valve repair shows long-term efficacy

By Reuters Staff NEW YORK (Reuters Health) - A large proportion of bicuspid aortic valve (BAV) repairs using a modified anatomy-based technique remain stable and lead to excellent long-term survival,

Depression and anxiety are biochemically different

By Megan Brooks NEW YORK (Reuters Health) - Depression and anxiety share similar symptoms and risk factors, often co-occur and are therefore assumed to be closely related. But for the first time a

U.S. FDA to tighten coronavirus vaccine authorization standards ahead of election -paper

By Reuters Staff (Reuters) - The U.S. Food and Drug Administration is expected to soon announce new, more stringent standards for an emergency authorization of a COVID-19 vaccine, lowering the chances

UK to host 'human challenge' trials for COVID-19 vaccines - FT

By Reuters Staff (Reuters) - Britain will host clinical trials where volunteers are deliberately infected with the new coronavirus to test the effectiveness of vaccine candidates, the Financial Times

Violence mounts against Iraqi doctors as COVID cases spike

By Amina Ismail NAJAF, Iraq (Reuters) - Iraqi doctor Tariq Al-Sheibani remembers little else beyond cowering on the ground as a dozen relatives of a patient, who had just died of COVID-19, beat him

Cytotoxic T cell therapy might be possible in COVID-19

By Reuters Staff (Reuters) - Cytotoxic T cell therapy may be feasible in patients with COVID-19 despite a potential hurdle, researchers say. The approach involves treating critically ill COVID-19

COVID-19 reinfections occur, but remain rare

By Reuters Staff (Reuters) - Another case of reinfection after recovery from COVID-19 has been reported, this time in a healthy young military healthcare provider at a U.S. Department of Defense

Most SARS-CoV-2 infections are symptomatic, study suggests

By Linda Carroll (Reuters Health) - Among those infected with SARS-CoV-2, only a minority will be asymptomatic, Swiss researchers say. In a systematic review that included nearly 80 studies of people

Non-physicians may optimize heart failure drugs remotely

By Marilynn Larkin NEW YORK (Reuters Health) - Remote optimization of drugs for heart failure patients with reduced ejection fraction (HFrEF) could support implementation of guideline-directed medical

Weekly insulin icodec is as effective as daily glargine in type 2 diabetics

By Reuters Staff (Reuters Health) - A 26-week phase 2 trial of insulin icodec has concluded that the experimental weekly therapy works as well and is just as safe for patients with type 2 diabetes as

Weekly insulin icodec is as effective as daily glargine in type 2 diabetics

By Reuters Staff (Reuters Health) - A 26-week phase 2 trial of insulin icodec has concluded that the experimental weekly therapy works as well and is just as safe for patients with type 2 diabetes as

Night-to-night variability in respiratory events among apnea patients

By Lisa Rapaport (Reuters Health) - Individual patients with obstructive sleep apnea may experience considerable night-to-night variability in respiratory events, a recent meta-analysis suggests.

U.S. health agency sets Oct. 16 deadline for states to submit vaccine plans

By Julie Steenhuysen and Manojna Maddipatla (Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday set an Oct. 16 deadline for states to submit plans for distributing COVID-

Low-dose glucocorticoids for rheumatoid arthritis may still carry some risk of serious infections

By Will Boggs MD NEW YORK (Reuters Health) - Even low-dose glucocorticoid treatment is associated with an increased risk of serious infection in patients with rheumatoid arthritis (RA), according to a

Severe COVID-19 less common in patients with GI symptoms

By Reuters Staff (Reuters) - People with gastrointestinal symptoms related to the new coronavirus, like diarrhea, nausea and vomiting, may be significantly less likely to develop severe COVID-19 and

Antibody-binding might not neutralize SARS-CoV-2

By Reuters Staff (Reuters) - The spike protein on the surface of the new coronavirus helps it invade cells, and some antibodies being tested as treatments work by attaching to the spike and disabling

Tool sorts hospitalized COVID-19 patients by risk

By Reuters Staff (Reuters) - A simple 21-point scoring system helps assign hospitalized COVID-19 patients to different risk groups, UK researchers reported in The BMJ. The score takes 8 factors into

Previous COVID-19 not linked with childbirth complications

By Reuters Staff (Reuters) - For otherwise healthy women giving birth, previous exposure to the novel coronavirus appears not to impact labor and delivery, a new study suggests. From early April to

Shortage of naive T cells raises COVID-19 risk in elderly

By Reuters Staff (Reuters) - A lower supply of a certain type of immune cell in older people that is critical to fighting foreign invaders may help explain their vulnerability to severe COVID-19,

Povidone-iodine nasal spray may help limit coronavirus spread

By Reuters Staff (Reuters) - An antiseptic nasal spray containing povidone-iodine may help curb transmission of the new coronavirus, preliminary research suggests. In test tube experiments,

Not all COVID-19 antibody tests are equal

By Reuters Staff (Reuters) - Some COVID-19 antibody tests are much more reliable than others. But even with the best ones, reliability varies among patient subgroups, a new study suggests. In a study

COVID-19 has disrupted cancer care, particularly among minority groups

By Megan Brooks NEW YORK (Reuters Health) - The COVID-19 pandemic has led to significant disruptions in routine cancer care, especially among racial and ethnic minority groups, according to the COVID-

Corneal-cell injection ongoing success in bullous keratopathy

By Reuters Staff NEW YORK (Reuters Health) - Most patients who underwent injection of cultured human corneal endothelial cells (hCECs) more than five years ago because of corneal endothelial failure

Gestational age at birth linked to brain volume at age 10

By Anne Harding NEW YORK (Reuters Health) - Gestational age at birth (GAB) is associated with brain morphometry at 10 years of age, even for children delivered at term, new findings show. "The longer

Transthoracic echocardiography feasible during prone-position ventilation

By Will Boggs MD NEW YORK (Reuters Health) - A few modifications in technique make it possible to perform transthoracic echocardiography (TTE) during prone position ventilation, researchers in Mexico

Cough syrups' sweetness, viscosity drive their effectiveness

By Anne Harding NEW YORK (Reuters Health) - Over-the-counter cough medicines help ease cough due to the common cold because they're sweet and viscous, not because they contain active ingredients like

Longer treatment delays, worse outcomes for in-hospital ischemic stroke

By Will Boggs MD NEW YORK (Reuters Health) - Times to reperfusion are longer and functional outcomes worse for patients with in-hospital ischemic stroke, compared with those having out-of-hospital

Macron says France must not lock up elderly in nursing homes as COVID-19 cases rise

By Reuters Staff PARIS (Reuters) - France must do everything possible to avoid locking up elderly people in nursing homes to protect them from a resurgence in coronavirus infections nationwide,

Pubmed articles

In order to help keep you abreast of current research we offer our PubMed feed. This section features the most recently published peer-reviewed studies in the 10 most common disease states.

Medical Jobs

Search healthcare jobs by specialty or location.


© 2020 /alert® unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
Privacy Policy | Terms of Use
Do Not Sell My Personal Information